Evidence map›Paper›PMID 32541893›Full record

ReviewNature reviews. Neurology2020

Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities.

Karen D Davis, Nima Aghaeepour, Andrew H Ahn, Martin S Angst, David Borsook, Ashley Brenton, Michael E Burczynski, Christopher Crean, Robert Edwards, Brice Gaudilliere and 16 more

2 registry-linked trialsOpen access · hybridAbstract readReviewConsensus Statement
In one paragraph

Review in Nature reviews. Neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 229 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
229citing papers in PubMed, 1 pooled it
28.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06030297 nacompletednot on this mapstarted 2023, after this paper: background citation

Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.

TypeinterventionalSponsorUniversity of UtahRan2023 to 2026Enrolled75ConditionsPeripheral NeuropathyArmsDiode Laser fiber type Selective Stimulator, ZTlido 1.8 % Topical System, PeriCam PSI NR, Medoc Quantitative Sensory Testing, Inactive Topical System
NCT06044584 recruitingnot on this mapstarted 2023, after this paper: background citation

Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool (pAIn-sense)

TypeobservationalSponsorETH ZurichRan2023 to 2028Enrolled150ConditionsNociceptive Pain, Neuropathic PainArmsNo intervention
3 · Its place in the literature

Who cites it

229 citing papers in PubMed, 1 synthesis or guideline pooled it, 469 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Effects ofPain reports · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

169 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 15 institutions in 3 countries.

Karen D DavisDepartment of Surgery and Institute of Medical Science, University of Toronto, Toronto, ON, Canada. karen.davis@uhnresearch.ca.ORCID http://orcid.org/0000-0003-1879-0090
Nima AghaeepourDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Andrew H AhnTeva Pharmaceuticals, Frazer, PA, USA.ORCID http://orcid.org/0000-0003-1780-9300
Martin S AngstDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.
David BorsookCenter for Pain and the Brain, Harvard Medical School, Boston, MA, USA.
Ashley BrentonMycroft Bioanalytics, Salt Lake City, UT, USA.
Michael E BurczynskiTeva Pharmaceutical Industries, Frazer, PA, USA.
Christopher CreanXyzagen, Pittsboro, NC, USA.ORCID http://orcid.org/0000-0001-5251-6998
Robert EdwardsPain Management Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Brice GaudilliereDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-3475-5706
Georgene W HergenroederThe Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA.ORCID http://orcid.org/0000-0002-6170-2191
Michael J IadarolaDepartment of Perioperative Medicine, Clinical Center, NIH, Rockville, MD, USA.
Smriti IyengarDivision of Translational Research, National Institute of Neurological Disorders and Stroke, NIH, Rockville, MD, USA.
Yunyun JiangThe Biostatistics Center, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.ORCID http://orcid.org/0000-0002-4438-1613
Jiang-Ti KongDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Sean MackeyDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Carl Y SaabDepartment of Neuroscience and Department of Neurosurgery, Carney Institute for Brain Science, Brown University, Providence, RI, USA.
Christine N SangDepartment of Anesthesiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Joachim ScholzNeurocognitive Disorders, Pain and New Indications, Biogen, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4284-8547
Marta SegerdahlAsarina Pharma, Copenhagen, Denmark.
Irene TraceyNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Christin VeasleyChronic Pain Research Alliance, Bethesda, MD, USA.
Jing WangDepartment of Anesthesiology, Perioperative Care and Pain Medicine, NYU School of Medicine, New York, NY, USA.
Tor D WagerDepartment of Psychological and Brain Sciences, Dartmouth College, Hanover, NH, USA.
Ajay D WasanAnesthesiology and Perioperative Medicine and Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
Mary Ann PelleymounterDivision of Translational Research, National Institute of Neurological Disorders and Stroke, NIH, Rockville, MD, USA.ORCID http://orcid.org/0000-0003-4051-122X
Stanford University · USBrigham and Women's Hospital · USNational Institute of Neurological Disorders and Stroke · USTeva Pharmaceuticals (United States) · USAllen Institute for Brain Science · USBiogen (United States) · USDartmouth College · USHarvard University · USMilken Institute · USNew York University · USPath BioAnalytics (United States) · USThe University of Texas Health Science Center at Houston · USUniversity Health Network · CAUniversity of Oxford · GBUniversity of Pittsburgh · US

Funding

Discovery of Biomarker Signatures Prognostic for Neuropathic Pain after Acute Spinal Cord InjuryR61NS113329 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HERGENROEDER, GEORGENE W · 2019 to 2019
$2.5M
Neuroimaging and Mentoring in Translational Pain ResearchK24DA029262 · NIDA · STANFORD UNIVERSITY · PI MACKEY, SEAN C · 2010 to 2019
$1.9M
Discovery of Biomarker Signatures Prognostic for Neuropathic Pain after Acute Spinal Cord InjuryR33NS113329 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HERGENROEDER, GEORGENE W · 2024 to 2024
$1.4M
Predicting Analgesic Response to Acupuncture - A Practical ApproachK23AT008477 · NCCIH · STANFORD UNIVERSITY · PI KONG, JIANG-TI · 2015 to 2019
$739k
Role of Myeloid Derived Suppressor Cells in the Immune Response to SurgeryK23GM111657 · NIGMS · STANFORD UNIVERSITY · PI GAUDILLIERE, BRICE · 2014 to 2017
$524k
Integrative And Molecular Studies Of Pain And Pain ControlZIACL090033 · CLC · CLINICAL CENTER · PI MANNES, ANDREW · 2014 to 2025
$0k
NCCIH NIH HHS K23 AT008477NIDA NIH HHS K24 DA029262NIGMS NIH HHS K23 GM111657NINDS NIH HHS R33 NS113329NINDS NIH HHS R61 NS113329
6 · The paper itself

Abstract

Pain medication plays an important role in the treatment of acute and chronic pain conditions, but some drugs, opioids in particular, have been overprescribed or prescribed without adequate safeguards, leading to an alarming rise in medication-related overdose deaths. The NIH Helping to End Addiction Long-term (HEAL) Initiative is a trans-agency effort to provide scientific solutions to stem the opioid crisis. One component of the initiative is to support biomarker discovery and rigorous validation in collaboration with industry leaders to accelerate high-quality clinical research into neurotherapeutics and pain. The use of objective biomarkers and clinical trial end points throughout the drug discovery and development process is crucial to help define pathophysiological subsets of pain, evaluate target engagement of new drugs and predict the analgesic efficacy of new drugs. In 2018, the NIH-led Discovery and Validation of Biomarkers to Develop Non-Addictive Therapeutics for Pain workshop convened scientific leaders from academia, industry, government and patient advocacy groups to discuss progress, challenges, gaps and ideas to facilitate the development of biomarkers and end points for pain. The outcomes of this workshop are outlined in this Consensus Statement.

Indexed as

Analgesics, OpioidBiomarkersChronic PainEducationHumansNational Institutes of Health (U.S.)NeuroimagingOpioid EpidemicOpioid-Related DisordersPain ManagementTreatment OutcomeUnited StatesAnalgesics, OpioidBiomarkers

Identifiers

PMID32541893
PMCPMC7326705
OpenAlexW3035623431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.